Skip to main content
Log in

The effect of fat intake and antihypertensive drug therapy on serum lipid profile: a cross-sectional survey of serum lipids in male and female hypertensives

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The present study aimed to investigate the effect of betablocker with diuretics therapy on serum cholesterol and high density lipoprotein (HDL-C) lipids in cross-sectional data (age, sex, weight, and body mass index (BMI), smoking/alcoholic consumption) and supplemented vegetarian low-fat diet with daily low fat energy intake, salt intake, duration of drug therapy, and serum protein as effective measures of lowering blood pressure among hypertensives in both males and females. Hypertensive patients on betablocker and/or thiazide therapy were compared in cross-section study with their age, blood pressure, fat intake, serum lipid profile, BMI, and serum albumin in males and females. Dietary fat intake and serum lipid profile were income related. Betablocker and diuretics therapy in combination with dietary fat intervention was beneficial for prolonged dyslipidemia control. Serum cholesterol level was main contributing factor dependent on BMI, duration of drug, and socio-economic factors. Fat intake contributed in hypertension and serum cholesterol levels. A cross-sectional data analysis showed beneficial effects of “low fat-salt-smoking-alcohol consumption and combined polyunsaturated fatty acid with antihypertensive therapy approach” to keep normal dyslipidemia and hypertension. Low fat intake, low salt, smoking, alcohol consumption, and combination of dietary oil supplements with lipid betablockers and diuretic modulators were associated with low hypertension and controlled dyslipidemia in Asian sedentary population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Kasiske BL, Ma JZ, Kalil RS, Louis TA (1995) Effects of antihypertensive therapy on serum lipids. Ann Intern Med 122(2):133–141

    CAS  PubMed  Google Scholar 

  2. Hauf-Zachariou U, Widmann L, Zülsdorf B, Hennig M, Lang PD (1993) A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia. Eur J Clin Pharmacol 45(2):95–100

    Article  CAS  PubMed  Google Scholar 

  3. Neaton JD, Grimm RH Jr, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, Cutler JA, Flack JM, Schoenberger JA, McDonald R et al (1993) Treatment of mild hypertension study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 270(6):713–724

    Article  CAS  PubMed  Google Scholar 

  4. Ostman J, Asplund K, Bystedt T, Dahlöf B, Jern S, Kjellström T, Lithell H (1998) Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group. J Intern Med 244(2):95–107

    Article  CAS  PubMed  Google Scholar 

  5. Foss OP, Graff-Iversen S, Istad H, Søyland E, Tjeldflaat L, Graving B (1999) Treatment of hypertensive and hypercholesterolaemic patients in general practice. The effect of captopril, atenolol and pravastatin combined with life style intervention. Scand J Prim Health Care 17(2):122–127

    Article  CAS  PubMed  Google Scholar 

  6. Gordon NF, Scott CB, Duncan JJ (1997) Effects of atenolol versus enalapril on cardiovascular fitness and serum lipids in physically active hypertensive men. Am J Cardiol 79(8):1065–1069

    Article  CAS  PubMed  Google Scholar 

  7. Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J et al (1998) Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med 158(7):741–751

    Article  CAS  PubMed  Google Scholar 

  8. López NC, Corral JL, Rincón LA, Arreaza MR, Giralt J, Galué GA, Barrios YE, Arocha I (1991) Nitrendipine and atenolol in essential hypertension in young and middle-aged patients: effect on serum lipids and left ventricular mass. J Cardiovasc Pharmacol 18(Suppl 1):S101–S105

    PubMed  Google Scholar 

  9. Grimm RH Jr, Flack JM, Grandits GA, Elmer PJ, Neaton JD, Cutler JA, Lewis C, McDonald R, Schoenberger J, Stamler J (1996) Long-term effects on plasma lipids of diet and drugs to treat hypertension Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA 275(20):1549–1556

    Article  CAS  PubMed  Google Scholar 

  10. Diestelhorst M, Larsson LI, European-Canadian Latanoprost Fixed Combination Study Group (2006) A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components. Ophthalmology 113(1):70–76

    Article  PubMed  Google Scholar 

  11. Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED (1999) Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 159(6):551–558

    Article  CAS  PubMed  Google Scholar 

  12. Fogari R, Zoppi A, Corradi L, Preti P, Mugellini A, Lusardi P (1999) Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol 33(4):534–539

    Article  CAS  PubMed  Google Scholar 

  13. Batic-Mujanovic O, Beganlic A, Salihefendic N, Pranjic N, Kusljugic Z (2008) Influence of smoking on serum lipid and lipoprotein levels among family medicine patients. Med Arh 62(5–6):264–267

    PubMed  Google Scholar 

  14. Medical Research Council Working Party (1985) Medical Research Council trial on treatment of mild hypertension prospective results: Brit Med J 291:97

    Google Scholar 

  15. Williams GH, Braunwald E (2007) Hypertensive vascular disease. In: Braunwald E et al (eds) Harrison’s “principles of internal medicine”. McGraw Hill Book Company, New York, 1024 pp

    Google Scholar 

  16. Sankar D, Rao MR, Sambandam G, Pugalendi KV (2006) Effect of sesame oil on diuretics or beta-blockers in the modulation of blood pressure, anthropometry, lipid profile and redox status. Yale J Biol Med 79(1):19–26

    CAS  PubMed  Google Scholar 

  17. Salvetti A, Ghiadoni L (2006) Thiazide diuretics in the treatment of hypertension an update. J Am Soc Nephrol 17(4 Suppl 2):S25–S29

    Article  CAS  PubMed  Google Scholar 

  18. Kozaki K (2005) Management of elderly hypertensive individuals with hyperlipidemia. Nippon Rinsho 63(6):1061–1066

    PubMed  Google Scholar 

  19. Papadakis JA, Mikhailidis DP, Vrentzos GE, Kalikaki A, Kazakou I, Ganotakis ES (2005) Effect of antihypertensive treatment on plasma fibrinogen and serum HDL levels in patients with essential hypertension. Clin Appl Thromb Hemost 11(2):139–146

    Article  CAS  PubMed  Google Scholar 

  20. Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O (2003) Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). J Hypertens 21(8):1563–1574

    Article  CAS  PubMed  Google Scholar 

  21. McCarron DA, Reusser ME (2001) Reducing cardiovascular disease risk with diet. Obes Res 9(Suppl 4):335–340

    Article  Google Scholar 

  22. Grossman E, Messerli FH (2002) Why beta-blockers are not cardioprotective in elderly patients with hypertension. Curr Cardiol Rep 4(6):468–473

    Article  PubMed  Google Scholar 

  23. Weir MR, Moser M (2000) Diuretics and beta-blockers: is there a risk for dyslipidemia? Am Heart J 139(1 Pt 1):174–183

    Article  CAS  PubMed  Google Scholar 

  24. Ames R (1998) Hyperlipidemia of diuretic therapy. Arch Mal Coeur Vaiss 91(Suppl):23–27

    PubMed  Google Scholar 

  25. Preuss HG, Burris JF (1996) Adverse metabolic effects of antihypertensive drugs. Implications for treatment. Drug Saf 14(6):355–364

    Article  CAS  PubMed  Google Scholar 

  26. Wenzel RR (2005) Renal protection in hypertensive patients: selection of antihypertensive therapy. Drugs 65(Suppl 2):29–39

    Article  CAS  PubMed  Google Scholar 

  27. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J et al (2002) African American Study of Kidney Disease and Hypertension Study Group Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288(19):2421–2431

    Article  CAS  PubMed  Google Scholar 

  28. Rovin BH, Hebert LA (2007) Thiazide diuretic monotherapy for hypertension: diuretic’s dark side just got darker. Kidney Int 72(12):1423–1426

    Article  CAS  PubMed  Google Scholar 

  29. Whelton A (1999) Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 106(5B):13S–24S

    Article  CAS  PubMed  Google Scholar 

  30. Hansson L (1987) Mild hypertension: guidelines for treatment. Report on WHO/ISH guidelines: workshop on treatment of mild hypertension: National Board of Health and Welfare. Drug Information committee, Sweden, 75 pp

    Google Scholar 

  31. Gopalan C, Ramashastri BV, Balasubramaniam (eds) Nutritive values of Indian foods. NVIF 2007. National Institute of Nutrition (ICMR) Publications, Hyderabad

  32. Doumas BT, Biggs HG (1972) Determination of serum albumin. In: Cooper GR (ed) Standard methods of clinical chemistry, vol 7. Academic Press, New York, 175 pp

    Google Scholar 

  33. Gustafsson JEC (1976) Improved specificity of serum albumin determination and estimation of “acute phase reactants” by use of the bromcresol green reaction. Clin Chem 22:616–622

    CAS  PubMed  Google Scholar 

  34. Senedicor GW, Cortron WG (1971) Statistical methods. Town State University Press, Iowa, 381 pp

    Google Scholar 

  35. Bays HE (2007) Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 99(6A):35C–43C

    Article  CAS  PubMed  Google Scholar 

  36. Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN et al (2007) Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study. Clin Ther 29(7):1354–1367

    Article  CAS  PubMed  Google Scholar 

  37. Holman RR, Paul S, Farmer A, Tucker L, Stratton IM, Neil HA et al (2009) Atorvastatin in factorial with omega-3 EE90 risk reduction in diabetes (AFORRD): a randomised controlled trial. Diabetologia 52(1):50–59

    Article  CAS  PubMed  Google Scholar 

  38. National Nutrition Monitoring Bureau Report (1984) National nutrition survey report. National Institute of Nutrition, Indian Council of Medical Research Publication, New Delhi, Hyderabad

    Google Scholar 

  39. Indian Council of Medical Research (1984) Recommended dietary intakes for Indians. Indian Council of Medical Research Publication, New Delhi, 18 pp

  40. Sharma R, Moffatt RJ, Singh RB, Katz JK (2010) Carotid artery disease: lipid lowering vs side effects of statins. In: Watson RD, Pradee B (eds) Modern dietary fat intake: promotion of disease. Integrated Press, India, 434 pp

  41. Little P, Girling G, Hasler A, Craven A, Trafford A (1990) The effect of a combination low sodium, low fat, high fibre diet on serum lipids in treated hypertensive patients. Eur J Clin Nutr 44(4):293–300

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The work is part of graduate MSc dissertation submitted by first author to National Institute of Nutrition (Indian Council of Medical Research), Hyderabad. The graduate supervision of Drs T. C. Raghuram, MD, PhD and Kamla Krishnaswamy, MD is highly appreciated. The mentorship of cardiothoracic surgery team and clinical facility at the unit of Dr U. Brahmaji Rao, MD is highly appreciated at Osmania General Hospital. The help of physicians at CSIR, RRL, NGRI, CCMB dispensaries is highly appreciated. The discussion and interpretation of data was performed at Department of Nutrition, Food and Exercise Science, College of Human Sciences, Florida State University with Professor Robert J. Moffatt, PhD, MPH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rakesh Sharma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, R., Raghuram, T.C., Rao, U.B. et al. The effect of fat intake and antihypertensive drug therapy on serum lipid profile: a cross-sectional survey of serum lipids in male and female hypertensives. Mol Cell Biochem 343, 37–47 (2010). https://doi.org/10.1007/s11010-010-0496-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-010-0496-4

Keywords

Navigation